PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 6 days 22 hours 11 minutes
PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times
PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times
Progress in Care for Patients With Lung Cancer: Evaluating the Evidence From Barcelona
Visit https://www.peervoice.com/TAM860 to view the entire programme with slides.
Paving the Way to Better Outcomes in EGFR-Mutant NSCLC: Time to Take a Step Further?
Visit https://www.peervoice.com/CSE860 to view the entire programme with slides.
Recognizing and Addressing Immune-Related Adverse Events: Key Strategies to Optimize Patient Outcomes With Immunotherapy
Visit https://www.peervoice.com/YGB860 to view the entire programme with slides.
Edging Towards a Brighter Long-Term Outlook in NSCLC: Immunotherapy Beyond the First-Line
Visit https://www.peervoice.com/EEB860 to view the entire programme with slides.
Raising the Bar in Relapsed/Refractory CLL Care: Translating the Evidence With New and Emerging Therapies to Practice
Visit https://www.peervoice.com/GAV860 to view the entire programme with slides.
Current and Emerging Strategies to Improve Identification and Treatment of aTTP
Current and Emerging Strategies to Improve Identification and Treatment of aTTP
Breakthroughs in ES-SCLC Care: What Immunotherapy Means for Patient Outcomes
Breakthroughs in ES-SCLC Care: What Immunotherapy Means for Patient Outcomes
Prevention and Management of Cardiovascular Adverse Events in Multiple Myeloma: Safe and Appropriate Use of Proteasome Inhibitors
Visit https://www.peervoice.com/GTR860 to view the entire programme with slides.
Immunotherapy for First-Line Treatment of Advanced NSCLC: Evolving Options to Refine Care
Visit https://www.peervoice.com/VKC860 to view the entire programme with slides.